Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 10, 2012, Pages 2447-2455

  Patel, Sonali S ^a   Burns, Trudy L ^a,b   Botto, Lorenzo D ^c   Riehle Colarusso, Tiffany J ^d   Lin, Angela E ^e,f   Shaw, Gary M ^g   Romitti, Paul A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^e MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrioventricular canal defect; Atrioventricular septal defect; Cigarette smoking; Congenital; Defect; Endocardial cushion; Heart defects; Risk factors; Secondhand smoke exposure

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CIGARETTE SMOKING; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG USE; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MOTHER; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; PELVIC INFLAMMATORY DISEASE; PERINATAL PERIOD; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; TELEPHONE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; ENDOCARDIAL CUSHION DEFECTS; FEMALE; HEART SEPTAL DEFECTS; HUMANS; INFANT, NEWBORN; INTERVIEWS AS TOPIC; MALE; MATERNAL EXPOSURE; PRECONCEPTION CARE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION; YOUNG ADULT;

EID: 84866521126     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35555     Document Type: Article

References (46)

1. Alverson CJ, Strickland MJ, Gilboa SM, Correa A. 2011. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 127: e647-e653.
2. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J, Addicks K. 1999. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43: 675-684.
3. Botto LD, Correa A, Erickson JD. 2001a. Racial and temporal variations in the prevalence of heart defects. Pediatrics 107: E32.
4. Botto LD, Lynberg MC, Erickson JD. 2001b. Congenital heart defects, maternal febrile illness, and multivitamin use: A population-based study. Epidemiology 12: 485-490.
5. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A. National Birth Defects Prevention Study. 2007. Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79: 714-727.
6. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA. 2011. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 204: 314.e1-314.e11.
7. Browne ML, Rasmussen SA, Hoyt AT, Waller DK, Druschel CM, Caton AR, Canfield MA, Lin AE, Carmichael SL, Romitti PA. 2009. Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 85: 621-628.
8. Byrd RS, Howard CR. 1995. Children's passive and prenatal exposure to cigarette smoke. Pediatr Ann 24: 640-642 644-645.
9. Carmichael SL, Shaw GM, Iovannisci DM, Yang W, Finnell RH, Cheng S, Lammer EJ. 2006. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am J Med Genet Part A 140A: 2433-2440.
10. Carter TC, Olney RS, Mitchell AA, Romitti PA, Bell EM, Druschel CM. 2011. Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol 91: 108-116.
11. Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti PA, Mitchell AA, Olney RS, Correa A, for the National Birth Defects Prevention Study. 2009. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 54: 63-70.
12. Cleves MA, Malik S, Yang S, Carter TC, Hobbs CA. 2008. Maternal urinary tract infections and selected cardiovascular malformations. Birth Defects Res A Clin Mol Teratol 82: 464-473.
13. Cogswell ME, Bitsko RH, Anderka M, Caton AR, Feldkamp ML, Hockett Sherlock SM, Meyer RE, Ramadhani T, Robbins JM, Shaw GM, Mathews TJ, Royle M, Reefhuis J. 2009. Control selection and participation in an ongoing, population-based, case-control study of birth defects: The National Birth Defects Prevention Study. Am J Epidemiol 170: 975-985.
14. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DK, Reece EA. 2008. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199: 237.e1-237.e9.
15. Cresci M, Foffa I, Ait-Ali L, Pulignani S, Gianicolo EAL, Botto N, Picano E, Andreassi MG. 2011. Maternal and paternal environmental risk factors, metabolizing GSTM1 and GSTT1 polymorphisms, and congenital heart disease. Am J Cardiol 108: 1625-1631.
16. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. 2009. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 163: 978-985.
17. Dietz PM, Homa D, England LJ, Burley K, Tong VT, Dube SR, Bernert JT. 2011. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol 173: 355-359.
18. Ferencz C, Rubin JD, Loffredo C, Magee CA. 1993. Epidemiology of congenital heart disease: The Balitmore-Washington Infant Study: 1981-1989. Mount Kisco, NY: Futura Publishing Co.
19. Ferencz C, Correa-Villasenor A, Loffredo CA. 1997. Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore-Washington Infant Study: 1981-1989. Armonk, NY: Futura Publishing Co. 463 pp.
20. Gilboa SM, Correa A, Botto LD, Rasmussen SA, Waller DK, Hobbs CA, Cleves MA, Riehle-Colarusso TJ. 2010. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 202: 51.e1-51.e10.
21. Hartman RJ, Riehle-Colarusso T, Lin A, Frias JL, Patel SS, Duwe K, Correa A, Rasmussen SA. 2011. Descriptive study of nonsyndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005. Am J Med Genet Part A 155A: 555-564.
22. Hoffman JI, Kaplan S, Liberthson RR. 2004. Prevalence of congenital heart disease. Am Heart J 147: 425-439.
23. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL, American Heart Association Council on Cardiovascular Disease in the Y. 2007. Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014.
24. Kelley K, Kelley T, Kaufman DW, Mitchell AA. 2003. The Slone Drug Dictionary: A research-driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 12: S168-S169.
25. Li Z, Liu J, Ye R, Zhang L, Zheng X, Ren A. 2010. Maternal passive smoking and risk of cleft lip with or without cleft palate. Epidemiology 21: 240-242.
26. Loffredo CA, Hirata J, Wilson PD, Ferencz C, Lurie IW. 2001a. Atrioventricular septal defects: Possible etiologic differences between complete and partial defects. Teratology 63: 87-93.
27. Loffredo CA, Wilson PD, Ferencz C. 2001b. Maternal diabetes: An independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64: 98-106.
28. Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA. 2008. Maternal smoking and congenital heart defects. Pediatrics 121: e810-e816.
29. Mathews TJ, Rivera CC. 2004. Smoking during pregnancy-United States, 1990-2002. MMWR Morb Mortal Wkly Rep 53: 911-915.
30. Miller EA, Manning SE, Rasmussen SA, Reefhuis J, Honein MA. 2009. Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia: National Birth Defects Prevention Study 1997-2003. Paediatr Perinat Epidemiol 23: 9-17.
31. Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. 2009. Recurrence of congenital heart defects in families. Circulation 120: 295-301.
32. Patel SS. 2010. Non-syndromic atrioventricular septal defects: a refined definition, association risk factors, and prognostic risk factors for left atrioventricular valve replacement following primary repair [Dissertation]. Iowa City: University of Iowa. 275 pp.
33. Pierpont ME, Markwald RR, Lin AE. 2000. Genetic aspects of atrioventricular septal defects. Am J Med Genet 97: 289-296.
34. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193-201.
35. Reefhuis J, Honein MA, Schieve LA, Rasmussen SA. 2011. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. Hum Reprod 26: 451-457.
36. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. 2008. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 153: 807-813.
37. Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, Lammer EJ. 2005. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol 162: 1207-1214.
38. Sheffield VC, Pierpont ME, Nishimura D, Beck JS, Burns TL, Berg MA, Stone EM, Patil SR, Lauer RM. 1997. Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum Mol Genet 6: 117-121.
39. Smaill F. 2007. Asymptomatic bacteriuria in pregnancy. Best Pract Res Clin Obstet Gynaecol 21: 439-450.
40. Suarez L, Ramadhani T, Felkner M, Canfield MA, Brender JD, Romitti PA, Sun L. 2011. Maternal smoking, passive tobacco smoke, and neural tube defects. Birth Defects Res A Clin Mol Teratol 91: 29-33.
41. Tong VT, Jones JR, Dietz PM, D'Angelo D, Bombard JM. 2009. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveill Summ 58: 1-29.
42. Torfs CP, Christianson RE, Iovannisci DM, Shaw GM, Lammer EJ. 2006. Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis. Birth Defects Res A Clin Mol Teratol 76: 723-730.
43. van Beynum IM, Mooij C, Kapusta L, Heil S, den Heijer M, Blom HJ. 2008. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects. Clin Chem Lab Med 46: 1369-1375.
44. Waller DK, Gallaway MS, Taylor LG, Ramadhani TA, Canfield MA, Scheuerle A, Hernandez-Diaz S, Louik C, Correa A. 2010. Use of oral contraceptives in pregnancy and major structural birth defects in offspring. Epidemiology 21: 232-239.
45. Windham GC, Hopkins B, Fenster L, Swan SH. 2000. Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 11: 427-433.
46. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. 2001. The National Birth Defects Prevention Study. Public Health Rep 116: 32-40.